CSI Market
Sign In | Register

American Bio Medica (ABMC) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access ABMC Annual Cash Flow →
Looking at cash flow data from American Bio Medica through Mar 31 2022 provides insight into Mar 31 2023's financial flexibility across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2023)
3 Months 		(Dec 31 2022) (Sep 30 2022) (Jun 30 2022) (Mar 31 2022)
Operating Activities
Income1.88
Depreciation & amortization0.01
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Other Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Other Assets-2.11
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Provision For Reduction Of Doubtful Accounts-
Gain Loss On Disposition Of Property-
Provision For Bad Debts-
Penalty Added To Loan Balance-
Director Fee Paid With Restricted Stock-
Increaase Decrease Operating Lease Right Of Use Asset Current-
Non Cash Loan Penalty-
Provision For Slow Moving And Obsolete Inventory-0.02
Finance Lease Right Of Use Asset Amortization0.02
Stock Issued During Period Value Issued For Services0.02
Debt Instrument Decrease Forgiveness-
Right Of Use Asset Obtained In Exchange For Finance Lease Liability-0.02
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable-0.07
Increase (Decrease) in Accounts Payable0.02
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities-0.18
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.08
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-0.36
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Patent Application Costs-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.25
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.25
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.15
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Deferred Finance Costs-
Forgiveness Of Proceeds From Ppp Loan-
Proceeds From Lincoln Park Financing-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.15
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-0.36
Total Cash Flow0.03
4 historic quarters locked

Sign in to unlock the full American Bio Medica cash flow history.

Sign In Create Free Account

About American Bio Medica Corp Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001654954-23-007911

Figures are derived from filed reports and may be restated. Historical data is subject to revision.